UNILABS A/S: Financial statements 2021
CVR: 29458219
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
UNILABS A/S (CVR 29458219) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 59,903,000 and a net result of DKK 16,124,000 compared with DKK 9,294,000 the year before. That is an increase of 19.7% compared with the year before. Equity in the 2021 report amounted to DKK 121,889,000. The solvency ratio was 81.4%. The company had 55 employees in the financial year.
- Gross Profit
- DKK 59,903,000
- Profit/Loss
- DKK 16,124,000
- Equity
- DKK 121,889,000
- Total Assets
- DKK 149,694,000
- Employees
- 55
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 59.9 mio. | 16.1 mio. | 121.9 mio. | 55 |
| 2020 | - | 50 mio. | 9.3 mio. | 105.8 mio. | 59 |
| 2019 | - | 53.6 mio. | 12.1 mio. | 96.5 mio. | 80 |
| 2018 | - | 52.7 mio. | 12.1 mio. | 84.3 mio. | 75 |
| 2017 | - | 60.8 mio. | 6.8 mio. | 72.3 mio. | 75 |
Official annual report
Find more companies like UNILABS A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
UNILABS A/S has published its annual report for 2020. Gross profit came to DKK 50,039,000, and the net result was DKK 9,294,000.
As of June 1, 2021, Peder Søren Andersen has joined the board of directors of UNILABS A/S.
As of June 1, 2021, Peder Søren Andersen is registered as director of UNILABS A/S.
As of May 31, 2021, Jakob Oemar Gjørret has left the board of directors of UNILABS A/S.
As of May 31, 2021, Jakob Oemar Gjørret has stepped down as adm. dir. of UNILABS A/S.
About UNILABS A/S
UNILABS A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 1969. The company is registered under the industry Billeddiagnostiske undersøgelser og medicinske laboratorieaktiviteter. The company was previously named CAPIO DIAGNOSTIK A/S and NOVA MEDICAL MEDI-LAB A/S. The management consists of Amar Rauf. The board consists of Thomas Axel Per Lindahl (chair), Amar Rauf and Eric Schuh. The company is owned by Unilabs Laboratoire d'Analyses Médicales SA. The company has 47 employees (2026). In 2025, the company reported a gross profit of DKK 74,330,000 and a net result of DKK 37,726,000 compared with DKK 44,593,000 the year before. Equity in the 2025 report amounted to DKK 90,050,000.